Industrial - Machinery
Compare Stocks
2 / 10Stock Comparison
PH vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
PH vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery |
| Market Cap | $113.93B | $83.18B |
| Revenue (TTM) | $20.99B | $18.32B |
| Net Income (TTM) | $3.48B | $2.44B |
| Gross Margin | 37.2% | 39.4% |
| Operating Margin | 20.9% | 19.4% |
| Forward P/E | 29.1x | 22.8x |
| Total Debt | $9.64B | $13.76B |
| Cash & Equiv. | $467M | $1.54B |
PH vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Parker-Hannifin Cor… (PH) | 100 | 501.6 | +401.6% |
| Emerson Electric Co. (EMR) | 100 | 242.4 | +142.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PH vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PH carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 7.4% 10Y total return vs EMR's 215.5%
- Lower volatility, beta 1.00, Low D/E 70.4%, current ratio 1.19x
- PEG 1.22 vs EMR's 5.04
EMR is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 37 yrs, beta 1.52, yield 1.4%
- Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
- 3.0% revenue growth vs PH's -0.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs PH's -0.4% | |
| Value | Lower P/E (22.8x vs 29.1x) | |
| Quality / Margins | 16.6% margin vs EMR's 13.3% | |
| Stability / Safety | Beta 1.00 vs EMR's 1.52 | |
| Dividends | 1.4% yield, 37-year raise streak, vs PH's 0.7% | |
| Momentum (1Y) | +48.2% vs EMR's +39.9% | |
| Efficiency (ROA) | 11.5% ROA vs EMR's 5.8%, ROIC 13.4% vs 8.2% |
PH vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PH vs EMR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
PH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PH and EMR operate at a comparable scale, with $21.0B and $18.3B in trailing revenue. Profitability is closely matched — net margins range from 16.6% (PH) to 13.3% (EMR). On growth, PH holds the edge at +10.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $21.0B | $18.3B |
| EBITDAEarnings before interest/tax | $5.1B | $4.7B |
| Net IncomeAfter-tax profit | $3.5B | $2.4B |
| Free Cash FlowCash after capex | $3.7B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +37.2% | +39.4% |
| Operating MarginEBIT ÷ Revenue | +20.9% | +19.4% |
| Net MarginNet income ÷ Revenue | +16.6% | +13.3% |
| FCF MarginFCF ÷ Revenue | +17.5% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +10.6% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -4.2% | +28.2% |
Valuation Metrics
EMR leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 33.3x trailing earnings, PH trades at a 9% valuation discount to EMR's 36.6x P/E. Adjusting for growth (PEG ratio), PH offers better value at 1.39x vs EMR's 8.11x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $113.9B | $83.2B |
| Enterprise ValueMkt cap + debt − cash | $123.1B | $95.4B |
| Trailing P/EPrice ÷ TTM EPS | 33.28x | 36.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.11x | 22.77x |
| PEG RatioP/E ÷ EPS growth rate | 1.39x | 8.11x |
| EV / EBITDAEnterprise value multiple | 24.78x | 18.89x |
| Price / SalesMarket cap ÷ Revenue | 5.74x | 4.62x |
| Price / BookPrice ÷ Book value/share | 8.58x | 4.13x |
| Price / FCFMarket cap ÷ FCF | 34.10x | 31.19x |
Profitability & Efficiency
PH leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
PH delivers a 24.3% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $12 for EMR. EMR carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to PH's 0.70x. On the Piotroski fundamental quality scale (0–9), PH scores 8/9 vs EMR's 7/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +24.3% | +12.1% |
| ROA (TTM)Return on assets | +11.5% | +5.8% |
| ROICReturn on invested capital | +13.4% | +8.2% |
| ROCEReturn on capital employed | +17.8% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.70x | 0.68x |
| Net DebtTotal debt minus cash | $9.2B | $12.2B |
| Cash & Equiv.Liquid assets | $467M | $1.5B |
| Total DebtShort + long-term debt | $9.6B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 11.39x | 6.61x |
Total Returns (Dividends Reinvested)
PH leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PH five years ago would be worth $29,479 today (with dividends reinvested), compared to $16,900 for EMR. Over the past 12 months, PH leads with a +48.2% total return vs EMR's +39.9%. The 3-year compound annual growth rate (CAGR) favors PH at 40.2% vs EMR's 22.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +1.2% | +9.3% |
| 1-Year ReturnPast 12 months | +48.2% | +39.9% |
| 3-Year ReturnCumulative with dividends | +175.4% | +84.1% |
| 5-Year ReturnCumulative with dividends | +194.8% | +69.0% |
| 10-Year ReturnCumulative with dividends | +741.1% | +215.5% |
| CAGR (3Y)Annualised 3-year return | +40.2% | +22.6% |
Risk & Volatility
Evenly matched — PH and EMR each lead in 1 of 2 comparable metrics.
Risk & Volatility
PH is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.00x | 1.52x |
| 52-Week HighHighest price in past year | $1034.96 | $165.15 |
| 52-Week LowLowest price in past year | $608.31 | $106.53 |
| % of 52W HighCurrent price vs 52-week peak | +87.2% | +89.6% |
| RSI (14)Momentum oscillator 0–100 | 33.9 | 48.4 |
| Avg Volume (50D)Average daily shares traded | 710K | 2.8M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates PH as "Buy" and EMR as "Buy". Consensus price targets imply 15.4% upside for PH (target: $1042) vs 9.5% for EMR (target: $162). For income investors, EMR offers the higher dividend yield at 1.42% vs PH's 0.73%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $1042.08 | $161.92 |
| # AnalystsCovering analysts | 38 | 41 |
| Dividend YieldAnnual dividend ÷ price | +0.7% | +1.4% |
| Dividend StreakConsecutive years of raises | 33 | 37 |
| Dividend / ShareAnnual DPS | $6.61 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | +1.5% |
PH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMR leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
PH vs EMR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is PH or EMR a better buy right now?
For growth investors, Emerson Electric Co.
(EMR) is the stronger pick with 3. 0% revenue growth year-over-year, versus -0. 4% for Parker-Hannifin Corporation (PH). Parker-Hannifin Corporation (PH) offers the better valuation at 33. 3x trailing P/E (29. 1x forward), making it the more compelling value choice. Analysts rate Parker-Hannifin Corporation (PH) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PH or EMR?
On trailing P/E, Parker-Hannifin Corporation (PH) is the cheapest at 33.
3x versus Emerson Electric Co. at 36. 6x. On forward P/E, Emerson Electric Co. is actually cheaper at 22. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Parker-Hannifin Corporation wins at 1. 22x versus Emerson Electric Co. 's 5. 04x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — PH or EMR?
Over the past 5 years, Parker-Hannifin Corporation (PH) delivered a total return of +194.
8%, compared to +69. 0% for Emerson Electric Co. (EMR). Over 10 years, the gap is even starker: PH returned +741. 1% versus EMR's +215. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PH or EMR?
By beta (market sensitivity over 5 years), Parker-Hannifin Corporation (PH) is the lower-risk stock at 1.
00β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 53% more volatile than PH relative to the S&P 500. On balance sheet safety, Emerson Electric Co. (EMR) carries a lower debt/equity ratio of 68% versus 70% for Parker-Hannifin Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — PH or EMR?
By revenue growth (latest reported year), Emerson Electric Co.
(EMR) is pulling ahead at 3. 0% versus -0. 4% for Parker-Hannifin Corporation (PH). On earnings-per-share growth, the picture is similar: Parker-Hannifin Corporation grew EPS 24. 2% year-over-year, compared to 17. 8% for Emerson Electric Co.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PH or EMR?
Parker-Hannifin Corporation (PH) is the more profitable company, earning 17.
8% net margin versus 12. 7% for Emerson Electric Co. — meaning it keeps 17. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PH leads at 20. 5% versus 19. 6% for EMR. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PH or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Parker-Hannifin Corporation (PH) is the more undervalued stock at a PEG of 1. 22x versus Emerson Electric Co. 's 5. 04x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Emerson Electric Co. (EMR) trades at 22. 8x forward P/E versus 29. 1x for Parker-Hannifin Corporation — 6. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PH: 15. 4% to $1042. 08.
08Which pays a better dividend — PH or EMR?
All stocks in this comparison pay dividends.
Emerson Electric Co. (EMR) offers the highest yield at 1. 4%, versus 0. 7% for Parker-Hannifin Corporation (PH).
09Is PH or EMR better for a retirement portfolio?
For long-horizon retirement investors, Parker-Hannifin Corporation (PH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
00), 0. 7% yield, +741. 1% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PH: +741. 1%, EMR: +215. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PH and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.